Skip to main content

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical Biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

Volume 9, Number 1, February 2008


ADAM10 as a Target for Anti-Cancer Therapy
pp. 2-8(7)
Authors: Moss, Marcia L.; Stoeck, Alexander; Yan, Wenbo; Dempsey, Peter J.


Matrix Metalloproteinase-9/Gelatinase B is a Putative Therapeutic Target of Chronic Obstructive Pulmonary Disease and Multiple Sclerosis
pp. 34-46(13)
Authors: Sang, Q.-X.; Muroski, M. E.; Roycik, M. D.; Newcomer, R. G.; Van den Steen, P. E.; Opdenakker, G.; Monroe, H. R.; Sahab, Z. J.


Free Content Joint Diseases and Matrix Metalloproteinases: A Role for MMP-13
pp. 47-54(8)
Authors: Takaishi, Hironari; Kimura, Tokuhiro; Dalal, Seema; Okada, Yasunori; D'Armiento, Jeanine


  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more